Concepts (470)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bayes Theorem | 73 | 2023 | 307 | 10.080 |
Why?
|
| Models, Statistical | 40 | 2020 | 448 | 5.770 |
Why?
|
| Spatial Analysis | 15 | 2021 | 33 | 2.960 |
Why?
|
| Disease Outbreaks | 12 | 2023 | 83 | 2.780 |
Why?
|
| Soil Pollutants | 13 | 2016 | 42 | 2.620 |
Why?
|
| Population Surveillance | 8 | 2018 | 285 | 2.450 |
Why?
|
| Cluster Analysis | 17 | 2019 | 219 | 2.290 |
Why?
|
| Space-Time Clustering | 11 | 2018 | 15 | 1.850 |
Why?
|
| Risk Assessment | 17 | 2018 | 2007 | 1.630 |
Why?
|
| Public Health | 8 | 2019 | 201 | 1.580 |
Why?
|
| Spatio-Temporal Analysis | 15 | 2021 | 28 | 1.500 |
Why?
|
| South Carolina | 41 | 2021 | 2752 | 1.500 |
Why?
|
| Communicable Diseases | 6 | 2016 | 50 | 1.440 |
Why?
|
| Models, Biological | 9 | 2021 | 981 | 1.430 |
Why?
|
| Data Interpretation, Statistical | 14 | 2017 | 329 | 1.390 |
Why?
|
| Intellectual Disability | 11 | 2014 | 114 | 1.380 |
Why?
|
| Metals | 7 | 2014 | 100 | 1.370 |
Why?
|
| Monte Carlo Method | 14 | 2020 | 124 | 1.310 |
Why?
|
| Geographic Mapping | 6 | 2020 | 19 | 1.300 |
Why?
|
| Geographic Information Systems | 7 | 2020 | 34 | 1.290 |
Why?
|
| Computer Simulation | 23 | 2023 | 706 | 1.280 |
Why?
|
| Humans | 136 | 2023 | 68618 | 1.250 |
Why?
|
| Food Supply | 5 | 2013 | 43 | 1.250 |
Why?
|
| Health Surveys | 5 | 2020 | 489 | 1.220 |
Why?
|
| Algorithms | 17 | 2022 | 1196 | 1.160 |
Why?
|
| Small-Area Analysis | 9 | 2017 | 11 | 1.160 |
Why?
|
| Incidence | 25 | 2018 | 1603 | 1.040 |
Why?
|
| Environmental Monitoring | 8 | 2014 | 180 | 0.990 |
Why?
|
| Lead | 9 | 2016 | 45 | 0.940 |
Why?
|
| Topography, Medical | 5 | 2016 | 10 | 0.940 |
Why?
|
| Environmental Exposure | 8 | 2016 | 269 | 0.930 |
Why?
|
| Zoonoses | 3 | 2020 | 12 | 0.930 |
Why?
|
| Public Health Surveillance | 4 | 2020 | 18 | 0.910 |
Why?
|
| Disease Susceptibility | 4 | 2021 | 179 | 0.900 |
Why?
|
| Markov Chains | 10 | 2020 | 133 | 0.890 |
Why?
|
| Measles | 3 | 2019 | 6 | 0.880 |
Why?
|
| Residence Characteristics | 11 | 2021 | 252 | 0.880 |
Why?
|
| Epidemics | 1 | 2023 | 12 | 0.860 |
Why?
|
| Maternal Exposure | 6 | 2014 | 75 | 0.850 |
Why?
|
| Arsenic | 8 | 2016 | 46 | 0.820 |
Why?
|
| Biostatistics | 6 | 2019 | 43 | 0.820 |
Why?
|
| Epidemiologic Methods | 7 | 2016 | 83 | 0.810 |
Why?
|
| Biometry | 6 | 2017 | 72 | 0.810 |
Why?
|
| Infant, Low Birth Weight | 5 | 2014 | 84 | 0.800 |
Why?
|
| Epidemiology | 4 | 2016 | 14 | 0.790 |
Why?
|
| Dog Diseases | 2 | 2020 | 45 | 0.750 |
Why?
|
| Soil | 8 | 2014 | 51 | 0.740 |
Why?
|
| Echinococcosis | 1 | 2020 | 5 | 0.740 |
Why?
|
| Prenatal Exposure Delayed Effects | 4 | 2014 | 154 | 0.710 |
Why?
|
| Lung Neoplasms | 7 | 2020 | 1173 | 0.710 |
Why?
|
| Dental Enamel Hypoplasia | 1 | 2019 | 5 | 0.700 |
Why?
|
| Asthma | 4 | 2021 | 345 | 0.700 |
Why?
|
| Georgia | 11 | 2018 | 161 | 0.680 |
Why?
|
| Cholesterol, LDL | 1 | 2020 | 161 | 0.680 |
Why?
|
| Respiratory Tract Diseases | 1 | 2019 | 43 | 0.680 |
Why?
|
| Dental Caries | 1 | 2019 | 40 | 0.670 |
Why?
|
| Foot-and-Mouth Disease | 2 | 2011 | 2 | 0.660 |
Why?
|
| Metals, Heavy | 4 | 2014 | 18 | 0.660 |
Why?
|
| Regression Analysis | 7 | 2018 | 737 | 0.640 |
Why?
|
| Likelihood Functions | 8 | 2012 | 106 | 0.630 |
Why?
|
| Female | 54 | 2022 | 38074 | 0.590 |
Why?
|
| Epidemiological Monitoring | 6 | 2019 | 23 | 0.580 |
Why?
|
| Survival Analysis | 9 | 2019 | 714 | 0.580 |
Why?
|
| Pregnancy | 19 | 2021 | 2334 | 0.580 |
Why?
|
| Poisson Distribution | 13 | 2016 | 85 | 0.580 |
Why?
|
| Diabetes Mellitus | 2 | 2020 | 694 | 0.570 |
Why?
|
| Gene Ontology | 4 | 2019 | 31 | 0.560 |
Why?
|
| Statistics as Topic | 3 | 2016 | 219 | 0.550 |
Why?
|
| Sentinel Surveillance | 2 | 2006 | 20 | 0.550 |
Why?
|
| Epidemiologic Studies | 1 | 2016 | 33 | 0.550 |
Why?
|
| Databases, Factual | 5 | 2018 | 622 | 0.540 |
Why?
|
| Geography | 8 | 2021 | 80 | 0.530 |
Why?
|
| Mercury | 5 | 2014 | 34 | 0.510 |
Why?
|
| Child | 24 | 2021 | 6405 | 0.500 |
Why?
|
| Restaurants | 3 | 2013 | 29 | 0.480 |
Why?
|
| Walking | 2 | 2014 | 241 | 0.480 |
Why?
|
| Metalloids | 1 | 2014 | 2 | 0.480 |
Why?
|
| Male | 43 | 2021 | 37321 | 0.480 |
Why?
|
| Cardiovascular Diseases | 2 | 2020 | 940 | 0.470 |
Why?
|
| Environment | 3 | 2013 | 115 | 0.470 |
Why?
|
| Fetus | 2 | 2012 | 157 | 0.470 |
Why?
|
| Ovarian Neoplasms | 3 | 2022 | 267 | 0.470 |
Why?
|
| Data Mining | 4 | 2019 | 45 | 0.460 |
Why?
|
| Risk Factors | 17 | 2021 | 5731 | 0.460 |
Why?
|
| Software | 4 | 2022 | 418 | 0.460 |
Why?
|
| Obesity | 2 | 2020 | 1076 | 0.440 |
Why?
|
| Prevalence | 7 | 2020 | 1619 | 0.440 |
Why?
|
| Health Policy | 2 | 2016 | 221 | 0.430 |
Why?
|
| Neoplasms | 3 | 2013 | 1667 | 0.430 |
Why?
|
| Environmental Pollution | 4 | 2014 | 25 | 0.430 |
Why?
|
| Health Services Research | 1 | 2014 | 209 | 0.420 |
Why?
|
| Probability | 1 | 2013 | 245 | 0.420 |
Why?
|
| Urban Population | 4 | 2021 | 255 | 0.420 |
Why?
|
| Congresses as Topic | 4 | 2016 | 85 | 0.410 |
Why?
|
| Rural Population | 4 | 2021 | 398 | 0.410 |
Why?
|
| Diabetes Mellitus, Type 1 | 6 | 2012 | 529 | 0.400 |
Why?
|
| Developmental Disabilities | 5 | 2010 | 119 | 0.390 |
Why?
|
| Urbanization | 1 | 2010 | 4 | 0.370 |
Why?
|
| Health Status Disparities | 4 | 2021 | 326 | 0.370 |
Why?
|
| Hypertension | 1 | 2020 | 1535 | 0.370 |
Why?
|
| Disease Management | 1 | 2012 | 248 | 0.370 |
Why?
|
| Registries | 7 | 2022 | 733 | 0.370 |
Why?
|
| Chile | 2 | 2020 | 17 | 0.360 |
Why?
|
| Louisiana | 6 | 2019 | 37 | 0.360 |
Why?
|
| Prostatic Neoplasms | 6 | 2018 | 778 | 0.360 |
Why?
|
| Laryngeal Neoplasms | 5 | 2006 | 47 | 0.350 |
Why?
|
| Ambulatory Care Facilities | 1 | 2010 | 91 | 0.350 |
Why?
|
| Child, Preschool | 13 | 2021 | 3187 | 0.350 |
Why?
|
| Breast Neoplasms | 4 | 2021 | 1536 | 0.350 |
Why?
|
| Wasting Disease, Chronic | 1 | 2009 | 1 | 0.340 |
Why?
|
| Deer | 1 | 2009 | 4 | 0.340 |
Why?
|
| Aged | 15 | 2020 | 14862 | 0.340 |
Why?
|
| Hepatitis C | 1 | 2010 | 114 | 0.340 |
Why?
|
| Influenza, Human | 1 | 2010 | 79 | 0.330 |
Why?
|
| Adult | 21 | 2022 | 21403 | 0.330 |
Why?
|
| Infant, Newborn | 10 | 2019 | 2455 | 0.330 |
Why?
|
| Genome-Wide Association Study | 2 | 2022 | 240 | 0.330 |
Why?
|
| Disease Progression | 2 | 2021 | 1038 | 0.320 |
Why?
|
| Bias | 3 | 2021 | 148 | 0.320 |
Why?
|
| Middle Aged | 18 | 2020 | 21147 | 0.320 |
Why?
|
| Prospective Studies | 5 | 2021 | 3705 | 0.320 |
Why?
|
| Antiviral Agents | 1 | 2010 | 211 | 0.320 |
Why?
|
| Emergency Service, Hospital | 4 | 2022 | 711 | 0.320 |
Why?
|
| Systems Biology | 2 | 2019 | 25 | 0.310 |
Why?
|
| Women | 1 | 2008 | 40 | 0.310 |
Why?
|
| Exercise | 1 | 2014 | 658 | 0.310 |
Why?
|
| Scotland | 6 | 2019 | 18 | 0.310 |
Why?
|
| Adolescent | 16 | 2021 | 8912 | 0.300 |
Why?
|
| Rural Health | 1 | 2008 | 66 | 0.300 |
Why?
|
| Health Status Indicators | 1 | 2008 | 117 | 0.300 |
Why?
|
| Food | 1 | 2007 | 52 | 0.290 |
Why?
|
| Periodicals as Topic | 1 | 2010 | 158 | 0.290 |
Why?
|
| Linear Models | 4 | 2016 | 521 | 0.290 |
Why?
|
| Commerce | 1 | 2007 | 80 | 0.290 |
Why?
|
| Healthcare Disparities | 3 | 2019 | 378 | 0.280 |
Why?
|
| Online Systems | 1 | 2006 | 20 | 0.280 |
Why?
|
| Air Pollutants | 3 | 2021 | 75 | 0.280 |
Why?
|
| Models, Theoretical | 5 | 2018 | 384 | 0.280 |
Why?
|
| Gene Regulatory Networks | 2 | 2019 | 94 | 0.270 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 2019 | 1085 | 0.270 |
Why?
|
| Fascioliasis | 1 | 2005 | 1 | 0.260 |
Why?
|
| Abattoirs | 1 | 2005 | 4 | 0.260 |
Why?
|
| Cattle Diseases | 1 | 2005 | 2 | 0.260 |
Why?
|
| Cross-Sectional Studies | 5 | 2020 | 2279 | 0.260 |
Why?
|
| Communicable Diseases, Emerging | 2 | 2023 | 13 | 0.260 |
Why?
|
| SEER Program | 5 | 2019 | 153 | 0.240 |
Why?
|
| Chemical Hazard Release | 2 | 2016 | 40 | 0.240 |
Why?
|
| Socioeconomic Factors | 7 | 2021 | 955 | 0.240 |
Why?
|
| Chlorine | 2 | 2016 | 76 | 0.230 |
Why?
|
| Aged, 80 and over | 6 | 2018 | 4848 | 0.230 |
Why?
|
| Diet | 1 | 2007 | 514 | 0.230 |
Why?
|
| Ulmus | 1 | 2003 | 1 | 0.230 |
Why?
|
| Infant | 9 | 2014 | 2891 | 0.230 |
Why?
|
| Coleoptera | 1 | 2003 | 8 | 0.230 |
Why?
|
| Ivermectin | 1 | 2003 | 12 | 0.230 |
Why?
|
| Insect Control | 1 | 2003 | 16 | 0.230 |
Why?
|
| Insecticides | 1 | 2003 | 43 | 0.220 |
Why?
|
| United Kingdom | 4 | 2011 | 152 | 0.220 |
Why?
|
| Animals | 11 | 2020 | 20881 | 0.220 |
Why?
|
| Poverty | 6 | 2016 | 219 | 0.210 |
Why?
|
| Mental Disorders | 1 | 2008 | 659 | 0.210 |
Why?
|
| Communicable Disease Control | 1 | 2023 | 26 | 0.210 |
Why?
|
| Multimorbidity | 1 | 2022 | 7 | 0.210 |
Why?
|
| Risk | 6 | 2016 | 563 | 0.210 |
Why?
|
| Dogs | 2 | 2020 | 490 | 0.210 |
Why?
|
| Respiratory Tract Neoplasms | 4 | 2016 | 5 | 0.210 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2003 | 135 | 0.200 |
Why?
|
| Health Care Rationing | 1 | 2002 | 32 | 0.200 |
Why?
|
| United States | 15 | 2022 | 7367 | 0.200 |
Why?
|
| Particulate Matter | 1 | 2021 | 41 | 0.200 |
Why?
|
| Asymptomatic Infections | 1 | 2021 | 6 | 0.190 |
Why?
|
| Young Adult | 12 | 2021 | 5717 | 0.190 |
Why?
|
| Quarantine | 1 | 2021 | 3 | 0.190 |
Why?
|
| Depression, Postpartum | 1 | 2021 | 9 | 0.190 |
Why?
|
| England | 4 | 2021 | 64 | 0.190 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2012 | 536 | 0.190 |
Why?
|
| Echinococcus granulosus | 1 | 2020 | 1 | 0.190 |
Why?
|
| Argentina | 1 | 2020 | 9 | 0.190 |
Why?
|
| Social Class | 5 | 2016 | 127 | 0.180 |
Why?
|
| Health Services Accessibility | 2 | 2021 | 581 | 0.180 |
Why?
|
| Salmonella Infections | 2 | 2011 | 11 | 0.180 |
Why?
|
| Calcium | 2 | 2019 | 929 | 0.180 |
Why?
|
| Demography | 5 | 2018 | 279 | 0.180 |
Why?
|
| Retrospective Studies | 9 | 2021 | 7277 | 0.180 |
Why?
|
| Cohort Studies | 8 | 2016 | 2358 | 0.180 |
Why?
|
| Pregnancy Complications | 2 | 2021 | 286 | 0.180 |
Why?
|
| Reproducibility of Results | 4 | 2017 | 2077 | 0.180 |
Why?
|
| Zika Virus Infection | 1 | 2019 | 3 | 0.180 |
Why?
|
| Dengue | 1 | 2019 | 5 | 0.170 |
Why?
|
| Viral Vaccines | 1 | 2019 | 17 | 0.170 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2022 | 627 | 0.170 |
Why?
|
| Cities | 2 | 2009 | 29 | 0.160 |
Why?
|
| Trust | 1 | 2019 | 75 | 0.160 |
Why?
|
| Statistics, Nonparametric | 2 | 2012 | 306 | 0.160 |
Why?
|
| Leishmaniasis, Visceral | 1 | 2018 | 9 | 0.160 |
Why?
|
| Tularemia | 1 | 2018 | 4 | 0.160 |
Why?
|
| Cyclonic Storms | 1 | 2019 | 59 | 0.160 |
Why?
|
| Psychotherapy | 1 | 2021 | 253 | 0.160 |
Why?
|
| Racism | 1 | 2019 | 59 | 0.160 |
Why?
|
| Tick-Borne Diseases | 1 | 2018 | 20 | 0.160 |
Why?
|
| Homeostasis | 1 | 2019 | 291 | 0.150 |
Why?
|
| Sex Factors | 3 | 2017 | 1266 | 0.150 |
Why?
|
| Anxiety | 1 | 2021 | 422 | 0.150 |
Why?
|
| Multilevel Analysis | 1 | 2017 | 7 | 0.150 |
Why?
|
| Cognitive Dysfunction | 1 | 2021 | 176 | 0.150 |
Why?
|
| Autism Spectrum Disorder | 1 | 2019 | 111 | 0.150 |
Why?
|
| Cattle | 3 | 2005 | 475 | 0.150 |
Why?
|
| Hospitalization | 2 | 2022 | 978 | 0.150 |
Why?
|
| Logistic Models | 5 | 2016 | 1420 | 0.150 |
Why?
|
| Pandemics | 1 | 2021 | 352 | 0.150 |
Why?
|
| Air Pollution | 3 | 2000 | 54 | 0.150 |
Why?
|
| Physician-Patient Relations | 1 | 2019 | 261 | 0.140 |
Why?
|
| Biomarkers | 2 | 2019 | 1593 | 0.140 |
Why?
|
| Melanoma | 2 | 2017 | 335 | 0.140 |
Why?
|
| Pleural Neoplasms | 1 | 2016 | 7 | 0.140 |
Why?
|
| Multivariate Analysis | 5 | 2021 | 1046 | 0.140 |
Why?
|
| Neoplasm Staging | 3 | 2021 | 800 | 0.140 |
Why?
|
| Measles-Mumps-Rubella Vaccine | 1 | 2016 | 4 | 0.140 |
Why?
|
| Bronchial Neoplasms | 1 | 2016 | 12 | 0.140 |
Why?
|
| Peritoneal Neoplasms | 1 | 2016 | 23 | 0.140 |
Why?
|
| Mesothelioma | 1 | 2016 | 21 | 0.140 |
Why?
|
| Longitudinal Studies | 3 | 2016 | 1054 | 0.140 |
Why?
|
| Case-Control Studies | 5 | 2019 | 1553 | 0.140 |
Why?
|
| Disease | 2 | 2015 | 41 | 0.140 |
Why?
|
| Suicide | 1 | 2017 | 116 | 0.140 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2016 | 36 | 0.140 |
Why?
|
| Seasons | 2 | 2021 | 129 | 0.130 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2016 | 69 | 0.130 |
Why?
|
| Length of Stay | 1 | 2019 | 780 | 0.130 |
Why?
|
| Inhalation Exposure | 1 | 2016 | 33 | 0.130 |
Why?
|
| Alzheimer Disease | 1 | 2021 | 565 | 0.130 |
Why?
|
| Databases, Bibliographic | 1 | 2015 | 14 | 0.130 |
Why?
|
| Propensity Score | 3 | 2021 | 117 | 0.120 |
Why?
|
| Vaccination | 1 | 2016 | 189 | 0.120 |
Why?
|
| Mothers | 2 | 2016 | 172 | 0.120 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 3259 | 0.120 |
Why?
|
| Bronchitis | 1 | 2014 | 8 | 0.120 |
Why?
|
| Tanzania | 1 | 2014 | 35 | 0.120 |
Why?
|
| Malaria | 1 | 2014 | 26 | 0.120 |
Why?
|
| Refuse Disposal | 2 | 2010 | 22 | 0.120 |
Why?
|
| Industrial Waste | 2 | 2009 | 12 | 0.120 |
Why?
|
| Depression | 1 | 2021 | 943 | 0.110 |
Why?
|
| Sensitivity and Specificity | 2 | 2010 | 1753 | 0.110 |
Why?
|
| Lip Neoplasms | 2 | 2006 | 12 | 0.110 |
Why?
|
| Respiration Disorders | 1 | 2013 | 20 | 0.110 |
Why?
|
| Death Certificates | 1 | 1993 | 9 | 0.110 |
Why?
|
| Women's Health | 2 | 2019 | 148 | 0.110 |
Why?
|
| Principal Component Analysis | 2 | 2014 | 55 | 0.110 |
Why?
|
| Skin Neoplasms | 1 | 2017 | 375 | 0.110 |
Why?
|
| Patient Dropouts | 1 | 2014 | 98 | 0.110 |
Why?
|
| Antibodies, Antinuclear | 1 | 2014 | 171 | 0.110 |
Why?
|
| Colonic Neoplasms | 1 | 2015 | 299 | 0.110 |
Why?
|
| Autoimmunity | 1 | 2014 | 118 | 0.110 |
Why?
|
| Mental Health Services | 2 | 2021 | 199 | 0.110 |
Why?
|
| British Columbia | 1 | 2012 | 3 | 0.110 |
Why?
|
| Comorbidity | 3 | 2019 | 1426 | 0.110 |
Why?
|
| Telemedicine | 1 | 2021 | 700 | 0.110 |
Why?
|
| Exercise Therapy | 1 | 2014 | 183 | 0.100 |
Why?
|
| Research Design | 1 | 2016 | 729 | 0.100 |
Why?
|
| Functional Neuroimaging | 1 | 2012 | 82 | 0.100 |
Why?
|
| Livestock | 1 | 2011 | 2 | 0.100 |
Why?
|
| Veterans | 1 | 2019 | 904 | 0.100 |
Why?
|
| Head and Neck Neoplasms | 1 | 2017 | 561 | 0.100 |
Why?
|
| Social Environment | 1 | 2012 | 182 | 0.100 |
Why?
|
| Models, Neurological | 1 | 2012 | 136 | 0.100 |
Why?
|
| Survival Rate | 2 | 2010 | 1056 | 0.090 |
Why?
|
| Lung | 1 | 2016 | 849 | 0.090 |
Why?
|
| Interferon-beta | 1 | 2010 | 17 | 0.090 |
Why?
|
| Maps as Topic | 2 | 2000 | 2 | 0.090 |
Why?
|
| Asia | 1 | 2010 | 59 | 0.090 |
Why?
|
| Incineration | 1 | 2010 | 4 | 0.090 |
Why?
|
| Interferons | 1 | 2010 | 36 | 0.090 |
Why?
|
| Ribavirin | 1 | 2010 | 27 | 0.090 |
Why?
|
| Ohio | 1 | 2010 | 64 | 0.090 |
Why?
|
| Human papillomavirus 16 | 1 | 2010 | 23 | 0.090 |
Why?
|
| Joint Diseases | 1 | 2010 | 37 | 0.090 |
Why?
|
| Mouth Neoplasms | 3 | 2017 | 206 | 0.090 |
Why?
|
| Polyethylene Glycols | 1 | 2010 | 149 | 0.090 |
Why?
|
| Postal Service | 1 | 2009 | 19 | 0.090 |
Why?
|
| Premature Birth | 1 | 2011 | 150 | 0.090 |
Why?
|
| Environmental Health | 1 | 2009 | 23 | 0.090 |
Why?
|
| Parkinson Disease | 1 | 2012 | 272 | 0.090 |
Why?
|
| Infant, Premature | 1 | 2011 | 284 | 0.080 |
Why?
|
| Wisconsin | 1 | 2009 | 31 | 0.080 |
Why?
|
| Time Factors | 4 | 2021 | 4655 | 0.080 |
Why?
|
| Public Health Administration | 2 | 2016 | 36 | 0.080 |
Why?
|
| Housing | 3 | 2014 | 38 | 0.080 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2010 | 94 | 0.080 |
Why?
|
| Stroke | 1 | 2021 | 2163 | 0.080 |
Why?
|
| New Jersey | 1 | 2008 | 8 | 0.080 |
Why?
|
| Pregnancy, Animal | 1 | 1988 | 27 | 0.080 |
Why?
|
| Stereotyping | 1 | 2008 | 20 | 0.080 |
Why?
|
| Pregnancy, Multiple | 1 | 1988 | 32 | 0.080 |
Why?
|
| World Health Organization | 1 | 2008 | 53 | 0.080 |
Why?
|
| Social Adjustment | 1 | 2008 | 74 | 0.080 |
Why?
|
| Spectrum Analysis | 1 | 2008 | 81 | 0.080 |
Why?
|
| Data Collection | 1 | 2009 | 420 | 0.080 |
Why?
|
| Papillomavirus Infections | 1 | 2010 | 194 | 0.070 |
Why?
|
| Nutrition Policy | 1 | 2007 | 44 | 0.070 |
Why?
|
| Age Factors | 4 | 2017 | 1864 | 0.070 |
Why?
|
| Population Dynamics | 1 | 2007 | 30 | 0.070 |
Why?
|
| Liver Cirrhosis | 1 | 2010 | 301 | 0.070 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2010 | 300 | 0.070 |
Why?
|
| Surveys and Questionnaires | 3 | 2017 | 2800 | 0.070 |
Why?
|
| Fruit | 1 | 2007 | 86 | 0.070 |
Why?
|
| Vegetables | 1 | 2007 | 76 | 0.070 |
Why?
|
| Costs and Cost Analysis | 1 | 2007 | 193 | 0.070 |
Why?
|
| Metabolic Syndrome | 1 | 2009 | 191 | 0.070 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2007 | 70 | 0.070 |
Why?
|
| Boston | 1 | 2006 | 35 | 0.070 |
Why?
|
| Sampling Studies | 1 | 2006 | 80 | 0.070 |
Why?
|
| Belgium | 2 | 2016 | 18 | 0.070 |
Why?
|
| Dairy Products | 1 | 2006 | 13 | 0.070 |
Why?
|
| Germany, East | 1 | 2006 | 2 | 0.070 |
Why?
|
| Environmental Pollutants | 1 | 2008 | 180 | 0.070 |
Why?
|
| Preventive Medicine | 1 | 2006 | 48 | 0.070 |
Why?
|
| Magnesium | 1 | 2006 | 110 | 0.070 |
Why?
|
| Victoria | 1 | 2005 | 8 | 0.070 |
Why?
|
| Community Networks | 1 | 2006 | 96 | 0.060 |
Why?
|
| Sample Size | 2 | 1995 | 79 | 0.060 |
Why?
|
| Area Under Curve | 1 | 2006 | 238 | 0.060 |
Why?
|
| Social Support | 1 | 2008 | 423 | 0.060 |
Why?
|
| Esophageal Neoplasms | 1 | 2006 | 150 | 0.060 |
Why?
|
| Encephalopathy, Bovine Spongiform | 1 | 2005 | 2 | 0.060 |
Why?
|
| Railroads | 2 | 2016 | 15 | 0.060 |
Why?
|
| Spirometry | 2 | 2016 | 47 | 0.060 |
Why?
|
| Hazardous Waste | 2 | 1995 | 14 | 0.060 |
Why?
|
| Insulin Resistance | 1 | 2006 | 241 | 0.060 |
Why?
|
| Normal Distribution | 2 | 2015 | 46 | 0.060 |
Why?
|
| Neonicotinoids | 1 | 2003 | 2 | 0.060 |
Why?
|
| Plant Diseases | 1 | 2003 | 10 | 0.060 |
Why?
|
| Nitro Compounds | 1 | 2003 | 11 | 0.060 |
Why?
|
| Health Behavior | 1 | 2007 | 458 | 0.060 |
Why?
|
| Maternal Age | 2 | 2012 | 70 | 0.060 |
Why?
|
| Medicaid | 3 | 2012 | 302 | 0.060 |
Why?
|
| Plant Leaves | 1 | 2003 | 49 | 0.060 |
Why?
|
| CD4 Immunoadhesins | 1 | 2003 | 2 | 0.050 |
Why?
|
| Immunodominant Epitopes | 1 | 2003 | 13 | 0.050 |
Why?
|
| Protein Sorting Signals | 1 | 2003 | 11 | 0.050 |
Why?
|
| Receptors, IgE | 1 | 2003 | 22 | 0.050 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2003 | 40 | 0.050 |
Why?
|
| Sphingolipids | 2 | 2017 | 337 | 0.050 |
Why?
|
| Imidazoles | 1 | 2003 | 175 | 0.050 |
Why?
|
| Income | 2 | 2017 | 167 | 0.050 |
Why?
|
| Sudden Infant Death | 1 | 2002 | 6 | 0.050 |
Why?
|
| Gene Transfer Techniques | 1 | 2003 | 173 | 0.050 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2003 | 132 | 0.050 |
Why?
|
| Brain | 1 | 2012 | 2176 | 0.050 |
Why?
|
| North Carolina | 1 | 2002 | 224 | 0.050 |
Why?
|
| Equivalence Trials as Topic | 1 | 2021 | 7 | 0.050 |
Why?
|
| Pragmatic Clinical Trials as Topic | 1 | 2021 | 9 | 0.050 |
Why?
|
| Social Workers | 1 | 2021 | 11 | 0.050 |
Why?
|
| Midwifery | 1 | 2021 | 10 | 0.050 |
Why?
|
| Cross-Over Studies | 1 | 2021 | 260 | 0.050 |
Why?
|
| Base Sequence | 1 | 2003 | 1015 | 0.050 |
Why?
|
| Maternal Health Services | 1 | 2021 | 22 | 0.050 |
Why?
|
| Psychology | 1 | 2021 | 36 | 0.050 |
Why?
|
| Specialization | 1 | 2021 | 66 | 0.050 |
Why?
|
| Birth Weight | 2 | 2012 | 186 | 0.050 |
Why?
|
| Amino Acid Sequence | 1 | 2003 | 1083 | 0.050 |
Why?
|
| Germany | 1 | 2000 | 67 | 0.050 |
Why?
|
| Nurses | 1 | 2021 | 53 | 0.050 |
Why?
|
| Molecular Sequence Data | 1 | 2003 | 1447 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2003 | 481 | 0.040 |
Why?
|
| Dengue Virus | 1 | 2019 | 3 | 0.040 |
Why?
|
| Zika Virus | 1 | 2019 | 4 | 0.040 |
Why?
|
| Thailand | 1 | 2019 | 28 | 0.040 |
Why?
|
| Psychiatry | 1 | 2021 | 112 | 0.040 |
Why?
|
| Mortality | 1 | 2000 | 163 | 0.040 |
Why?
|
| Publications | 1 | 2019 | 17 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2003 | 597 | 0.040 |
Why?
|
| Genes, BRCA1 | 1 | 2019 | 47 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2010 | 7029 | 0.040 |
Why?
|
| Brazil | 1 | 2018 | 48 | 0.040 |
Why?
|
| Finland | 1 | 2018 | 13 | 0.040 |
Why?
|
| Rodentia | 1 | 2018 | 27 | 0.040 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2021 | 782 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2000 | 792 | 0.040 |
Why?
|
| User-Computer Interface | 1 | 2019 | 230 | 0.040 |
Why?
|
| DNA Fingerprinting | 1 | 2017 | 11 | 0.040 |
Why?
|
| Pharyngeal Neoplasms | 1 | 2017 | 8 | 0.040 |
Why?
|
| Genes | 1 | 2017 | 86 | 0.040 |
Why?
|
| Leukemia, Erythroblastic, Acute | 1 | 1997 | 15 | 0.040 |
Why?
|
| Stem Cell Factor | 1 | 1997 | 39 | 0.040 |
Why?
|
| Australia | 1 | 2018 | 235 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2019 | 880 | 0.040 |
Why?
|
| Genomics | 1 | 2018 | 168 | 0.040 |
Why?
|
| Computational Biology | 1 | 2018 | 190 | 0.030 |
Why?
|
| Erythropoietin | 1 | 1997 | 96 | 0.030 |
Why?
|
| Uncertainty | 1 | 2016 | 31 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 445 | 0.030 |
Why?
|
| Internet | 1 | 2019 | 390 | 0.030 |
Why?
|
| Textile Industry | 1 | 2016 | 6 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2016 | 274 | 0.030 |
Why?
|
| Pericardium | 1 | 2016 | 97 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2017 | 173 | 0.030 |
Why?
|
| France | 1 | 1995 | 26 | 0.030 |
Why?
|
| Age Distribution | 1 | 2016 | 320 | 0.030 |
Why?
|
| Poverty Areas | 1 | 2015 | 20 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2016 | 127 | 0.030 |
Why?
|
| Autistic Disorder | 1 | 2016 | 77 | 0.030 |
Why?
|
| ROC Curve | 1 | 2016 | 392 | 0.030 |
Why?
|
| Panama | 1 | 1995 | 6 | 0.030 |
Why?
|
| Survivors | 1 | 2017 | 256 | 0.030 |
Why?
|
| Forecasting | 1 | 2016 | 277 | 0.030 |
Why?
|
| Apgar Score | 1 | 1995 | 22 | 0.030 |
Why?
|
| Leukemia | 1 | 1995 | 117 | 0.030 |
Why?
|
| Parity | 1 | 1995 | 71 | 0.030 |
Why?
|
| Genes, Fungal | 1 | 2014 | 24 | 0.030 |
Why?
|
| PubMed | 1 | 2014 | 21 | 0.030 |
Why?
|
| Yeasts | 1 | 2014 | 15 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2014 | 65 | 0.030 |
Why?
|
| Prenatal Care | 1 | 1995 | 117 | 0.030 |
Why?
|
| Barium | 1 | 2014 | 52 | 0.030 |
Why?
|
| Disasters | 1 | 2016 | 204 | 0.030 |
Why?
|
| Mass Casualty Incidents | 1 | 2013 | 38 | 0.030 |
Why?
|
| Creatine | 1 | 2012 | 30 | 0.030 |
Why?
|
| Cause of Death | 1 | 1993 | 241 | 0.030 |
Why?
|
| Sex Ratio | 1 | 1992 | 13 | 0.030 |
Why?
|
| Face | 1 | 2012 | 46 | 0.030 |
Why?
|
| Vulnerable Populations | 1 | 2012 | 84 | 0.030 |
Why?
|
| Colorado | 1 | 2012 | 26 | 0.030 |
Why?
|
| Mathematical Computing | 1 | 2011 | 12 | 0.030 |
Why?
|
| Geography, Medical | 1 | 2011 | 1 | 0.020 |
Why?
|
| Food Industry | 1 | 2011 | 7 | 0.020 |
Why?
|
| Visual Perception | 1 | 2012 | 124 | 0.020 |
Why?
|
| Gestational Age | 1 | 2012 | 389 | 0.020 |
Why?
|
| Population Density | 1 | 2010 | 18 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 2010 | 219 | 0.020 |
Why?
|
| Causality | 1 | 2010 | 82 | 0.020 |
Why?
|
| Stochastic Processes | 1 | 2009 | 27 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2012 | 418 | 0.020 |
Why?
|
| Chromium | 1 | 2009 | 26 | 0.020 |
Why?
|
| Motor Activity | 1 | 2012 | 621 | 0.020 |
Why?
|
| Ireland | 1 | 1988 | 13 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 1851 | 0.020 |
Why?
|
| Twins | 1 | 1988 | 42 | 0.020 |
Why?
|
| Factor Analysis, Statistical | 1 | 2009 | 201 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2009 | 546 | 0.020 |
Why?
|
| Signal Transduction | 1 | 1997 | 2689 | 0.020 |
Why?
|
| Mass Screening | 1 | 2013 | 843 | 0.020 |
Why?
|
| Hawaii | 1 | 2007 | 24 | 0.020 |
Why?
|
| Lipids | 1 | 2009 | 298 | 0.020 |
Why?
|
| Regional Medical Programs | 1 | 2006 | 22 | 0.020 |
Why?
|
| Eating | 1 | 2006 | 119 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2009 | 1465 | 0.020 |
Why?
|
| Animal Feed | 1 | 2005 | 52 | 0.020 |
Why?
|
| Minerals | 1 | 2005 | 43 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2007 | 295 | 0.020 |
Why?
|
| Biological Products | 1 | 2005 | 78 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2009 | 1451 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 1745 | 0.010 |
Why?
|
| Tyrosine | 1 | 1997 | 196 | 0.010 |
Why?
|
| Cell Division | 1 | 1997 | 541 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1997 | 852 | 0.010 |
Why?
|
| Phosphorylation | 1 | 1997 | 1200 | 0.010 |
Why?
|
| Wind | 1 | 1992 | 2 | 0.010 |
Why?
|
| Weather | 1 | 1992 | 9 | 0.010 |
Why?
|
| Apoptosis | 1 | 1997 | 1641 | 0.010 |
Why?
|
| Child Care | 1 | 1968 | 13 | 0.010 |
Why?
|
| Mother-Child Relations | 1 | 1968 | 43 | 0.000 |
Why?
|
| Family | 1 | 1968 | 293 | 0.000 |
Why?
|
| Sibling Relations | 1 | 1968 | 4 | 0.000 |
Why?
|
| Child Rearing | 1 | 1968 | 8 | 0.000 |
Why?
|
| Father-Child Relations | 1 | 1968 | 6 | 0.000 |
Why?
|
| Methods | 1 | 1968 | 156 | 0.000 |
Why?
|
| Play and Playthings | 1 | 1968 | 22 | 0.000 |
Why?
|
| Family Characteristics | 1 | 1968 | 44 | 0.000 |
Why?
|
| Interview, Psychological | 1 | 1968 | 113 | 0.000 |
Why?
|
| Analysis of Variance | 1 | 1968 | 1040 | 0.000 |
Why?
|